Cellular and humoral immunity against human malignant melanoma
✍ Scribed by Giuseppe Fossati; Maria I. Colnaghi; Giuseppe Della Porta; Natale Cascinelli; Umberto Veronesi
- Publisher
- John Wiley and Sons
- Year
- 1971
- Tongue
- French
- Weight
- 558 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
The humoral and cellular immunological responses of melanoma patients against tumor‐associated antigens were studied by means of the indirect membrane immunofluorescence test and a microassay for cell‐mediated cytotoxicity. Melanoma target cells obtained from 22 different surgical specimens were used.
A total of 15 different sera were tested in 27 fluorescence assays. Humoral antibodies were found in all the 13 autochthonous sera tested: eight out of ten sera cross‐reacted with one or two allogeneic melanoma cells.
The 31 microassays performed with lymphocytes from 16 patients showed that effector cells specifically killed the melanoma target cells in seven out of 12 autochthonous tests and in 14 out of 19 allogeneic tests. No cytotoxicity was found when melanoma‐patient lymphocytes were tested against control cells or when control lymphocytes were tested against melanoma cells.
The observed cross‐reactivity pattern indicates that more than one tumor‐specific antigen may be present in melanoma cells.
📜 SIMILAR VOLUMES
The key issue in tumor immunology is to identify antigens as target structures for a cancer-selective immunological attack in the tumor-bearing host, resulting in tumor rejection. There is a growing detailed understanding of structural and regulatory gene alterations giving rise to candidate rejecti
## Abstract Leukocytes from 17 of 19 patients with urinary bladder carcinomas were cytotoxic for autochthonous as well as allogeneic bladder carcinoma cells in vitro. The cells from all 11 individual bladder carcinomas studied were susceptible to this cytotoxic action of patients' leukocytes. In co
We previously exploited the frequent overexpression of folate receptors on cancer cells to decorate malignant cell surfaces selectively with folate-hapten conjugates. In antihapten-immunized hosts, this targeted localization of foreign haptens to tumor cells led to rapid accumulation of autologous a